1. Home
  2. LPA vs ATYR Comparison

LPA vs ATYR Comparison

Compare LPA & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • ATYR
  • Stock Information
  • Founded
  • LPA 2013
  • ATYR 2005
  • Country
  • LPA United States
  • ATYR United States
  • Employees
  • LPA N/A
  • ATYR N/A
  • Industry
  • LPA
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LPA
  • ATYR Health Care
  • Exchange
  • LPA Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • LPA 196.1M
  • ATYR 105.8M
  • IPO Year
  • LPA N/A
  • ATYR 2015
  • Fundamental
  • Price
  • LPA $6.27
  • ATYR $1.05
  • Analyst Decision
  • LPA
  • ATYR Buy
  • Analyst Count
  • LPA 0
  • ATYR 6
  • Target Price
  • LPA N/A
  • ATYR $8.88
  • AVG Volume (30 Days)
  • LPA 10.3K
  • ATYR 16.3M
  • Earning Date
  • LPA 11-12-2025
  • ATYR 11-06-2025
  • Dividend Yield
  • LPA N/A
  • ATYR N/A
  • EPS Growth
  • LPA N/A
  • ATYR N/A
  • EPS
  • LPA 0.22
  • ATYR N/A
  • Revenue
  • LPA $45,924,457.00
  • ATYR N/A
  • Revenue This Year
  • LPA N/A
  • ATYR $420.85
  • Revenue Next Year
  • LPA N/A
  • ATYR $1,919.44
  • P/E Ratio
  • LPA $28.76
  • ATYR N/A
  • Revenue Growth
  • LPA 6.18
  • ATYR N/A
  • 52 Week Low
  • LPA $5.71
  • ATYR $0.97
  • 52 Week High
  • LPA $15.85
  • ATYR $7.29
  • Technical
  • Relative Strength Index (RSI)
  • LPA 48.76
  • ATYR 22.56
  • Support Level
  • LPA $6.10
  • ATYR $0.97
  • Resistance Level
  • LPA $6.62
  • ATYR $6.50
  • Average True Range (ATR)
  • LPA 0.26
  • ATYR 0.45
  • MACD
  • LPA 0.00
  • ATYR -0.53
  • Stochastic Oscillator
  • LPA 46.57
  • ATYR 1.46

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: